Exploring effective systemic treatments for liver cancer is still a great challenge worldwide.
As a novel form of regulated cell death, ferroptosis has been paid more and more attention …

Simple Summary Hepatocellular carcinoma (HCC) is the fifth most common cancer
worldwide and the second most common oncological reason for death. Liver resection and …

Transarterial chemoembolization (TACE) is commonly used for treating advanced
hepatocellular carcinoma (HCC). However, the instability of lipiodol-drug emulsion and the …

The process of transcatheter arterial chemoembolization is characterized by the ability to
accurately deliver chemotherapy drugs with minimal systemic side effects and has become …

Systemic drug delivery is the current clinically preferred route for cancer therapy. However,
challenges associated with tumor localization and off-tumor toxic effects limit the clinical …

Hepatocellular carcinoma (HCC) has the sixth-highest new incidence and fourth-highest
mortality worldwide. Transarterial chemoembolization (TACE) is one of the primary treatment …

Interventional embolization is one of the most common treatment strategies in the clinical
cancer treatment, especially in liver cancer (Sieghart et al., 2015). However, unstable …

Purpose Patients with unresectable intrahepatic cholangiocarcinoma (ICC) have poor
survival. Conventional transarterial chemoembolization (c-TACE) and drug-eluting beads …

Simple Summary The minimally invasive procedure of transarterial chemoembolization
(TACE) represents a standard oncologic procedure for the treatment of intermediate-stage …

Abstract This randomized, prospective, multicenter (12 centers in China) phase III trial
(Chinese Clinical Trial Registry# ChiCTR2000041170) compared drug-eluting bead …